cancer genetics inc
(CGIX:Consolidated Issue listed on NASDAQ Capital Market)
Edmund M. Cannon
Director, Chairman of Compensation Committee and Member of Audit Committee, Cancer Genetics, Inc.
|Age||Total Calculated Compensation||This person is connected to 13 board members in 1 different organizations across 1 different industries.|
See Board Relationships
Mr. Edmund M. Cannon is the Founder and President of the Clinical Research Center of Cape Cod, a Massachusetts company. Mr. Cannon was a Marketing and Operations consultant for Franey Medical Labs in Sandwich, Massachusetts, as well as heading up sales for the New England area for Pharmacia Diagnostics Inc., Piscataway, NJ and, at one time, Vice President and co-founder of Alletess, Inc., one of the first in-vitro labs in the United States. He has worldwide relationships ...
201 Route 17 NorthPhone: 201-528-9200
Rutherford, New Jersey 07070
Board Members Memberships*
Director, Chairman of Compensation Committee and Member of Audit Committee
Boston State College
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Douglas M. VanOort||Executive Chairman and Chief Executive Officer|
|Kenneth A. Berlin||Chief Executive Officer and President|
Rosetta Genomics, Ltd.
|Kimberly J. Popovits||Chairman, Chief Executive Officer, President and Member of Non-Management Stock Option Committee|
Genomic Health Inc.
|Thomas A. Bologna||Chairman and Chief Executive Officer|
Response Genetics, Inc
|Michael J. Pellini M.D., MBA||Chief Executive Officer and Director|
Foundation Medicine, Inc.
|$416.0K||Compensation as of Fiscal Year 2014.|